Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUT RESTORE-PAH
NCT07751120Phase 1Active, not recruiting
- Sponsor
- University of Minnesota
- Start
- Sep 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Phase 1, randomised trial in pulmonary arterial hypertension (PAH) (3 arms), sponsored by University of Minnesota. Primary endpoint: Donor engraftment comparison at 12 weeks. Started Sep 2026; status: active, not recruiting.
02
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT07751120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751120.